Adding oral diabetes pills to insulin for type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This trial looks at whether adding oral glucose-lowering drugs to your insulin can improve blood sugar control for adults with type 1 diabetes. It compares those who added these drugs to those who stayed on insulin alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes and are at least 18 years old.
- Your hemoglobin A1c (a measure of blood sugar control over 3 months) is 7% or higher.
- You have never taken any oral diabetes pills along with your insulin before now.
- You are willing to take your prescribed medications for at least 3 months.
- You are not currently in a severe health crisis like diabetic ketoacidosis, serious infection, or pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This study tests whether adding certain diabetes pills (GLP-1 receptor agonists or SGLT inhibitors) to insulin is safe and helpful for adults with type 1 diabetes. Doctors will check your glucose monitor data to see how well this works.
This trial tests if adding either cofrogliptin or linagliptin (two pills that help control blood sugar) to your current insulin treatment can improve diabetes control. It is for adults with type 2 diabetes whose blood sugar is still not well managed with insulin and certain other diabetes pills.
This trial is testing if adding a combination of SGLT-2 inhibitor and GLP-1 receptor agonist to metformin can improve blood sugar control in people with type 2 diabetes who are not meeting their goals on metformin alone or with one other pill.
This study tests if a new medicine (elecoglipron) combined with dapagliflozin is safe and works better for adults with type 2 diabetes that isn't well controlled by diet or other medications.
This trial tests a new GLP-1 receptor agonist to improve blood sugar control in people with type 2 diabetes. It may be an option if you haven't used a similar drug in the last three months and your medical records are complete.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.